Floatz logo

Cyclophosphamide

T-Lymphoblastic Lymphoma

Children's Oncology GroupSmall moleculePhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
81/ 100

Competitive context

45 Active assets in the T-Lymphoblastic Lymphoma cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
Children's Oncology Group
Phase 3BB
ASPARAGINASE
University of Washington
Phase 3BB
PEGASPARGASE
Children's Oncology Group
Phase 3BB
METHOTREXATE
Children's Oncology Group
Phase 3BB
DEXAMETHASONE
Children's Oncology Group
Phase 3BB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →